mosaique.info logo
  1. home
  2. article
  3. Africa faces mpox vaccine challenge

Africa faces mpox vaccine challenge

ai generated text

The majority of mpox cases have been reported in the Democratic Republic of Congo, with the country at the epicenter of a clade Ib outbreak declared a global health emergency. Sweden has recorded a case of a more dangerous variant, but does not currently have any doses of the vaccine. In contrast, African nations may receive vaccinations against mpox within days, with vaccines expected to arrive in the DRC and other countries by the end of next week. The World Health Organization has also declared the mpox outbreak a public health emergency of international concern.

    1. At present, WHO recommends the use of MVA-BN or LC16 vaccines, or the ACAM2000 vaccine when the others are not available.
    1. We can, and must, tackle mpox together – across regions and continents.
    2. We know how to control mpox. And, in the European region, the steps needed to eliminate its transmission altogether.
    3. The need for a coordinated response is now greatest in the African region.
    1. We didn't start vaccinations yet. We'll start in a few days if we are sure that everything is in place. End of next week, vaccines will start to arrive in DRC and other countries.
    2. Today, we are just talking about almost 200,000 doses (becoming) available. We need at least 10 million doses. The vaccine is so expensive — we can put it around $100 per dose. There are not so many countries in Africa that can afford the cost of this vaccine.
    3. We need to make sure that the supply chain management, the logistics are ready...to ensure that this vaccine will be safely stored and can be safely administered to people who need them.
    1. This is something that should concern us all.
    2. It's clear that a coordinated international response is essential to stop these outbreaks and save lives.
    1. What's happening in Africa is just the tip of the iceberg.
    2. Mpox, originating in Africa, was neglected there, and later caused a global outbreak in 2022. It is time to act decisively to prevent history from repeating itself.
    1. We have the capacity, but we need people to start placing orders pretty fast.
    1. Ebola was around for years, and it was only when it affected the Global North that anybody got interested in developing a vaccine.
    2. Their production was not necessarily geared to profit. It was geared equally to creating client relationships with other countries.
    3. Nobody's going to get rich selling vaccines to Africa.
    4. African countries don't have the resources to buy them and it's also not at all clear if the developed world is going to come up with the money.
    5. The current upsurge of mpox in parts of Africa, along with the spread of a new sexually transmissible strain of the monkeypox virus, is an emergency, not only for Africa, but for the entire globe.